Information  X 
Enter a valid email address

TMT Investments (TMT)

  Print   

Wednesday 24 June, 2020

TMT Investments

Holding(s) in Company

RNS Number : 9788Q
TMT Investments PLC
24 June 2020
 

24 June 2020

 

TMT INVESTMENTS PLC

("TMT" or the "Company")

 

Holding(s) in Company

 

TMT Investments PLC (AIM: TMT.L), the venture capital company investing in high-growth technology companies, announces that it was yesterday notified that, following the disposal of ordinary shares in the Company, Nelli Morgulchik's, whose shares are held through Macmillan Trading Company Limited, interest in the Company has decreased from 7,031,874 ordinary shares to 6,640,401 ordinary shares in the Company, representing 22.75% of the Company's issued ordinary share capital.

 

For further information contact :

 

TMT Investments PLC

Alexander Selegenev

Executive Director

www.tmtinvestments.com

 

 

+44 (0)1534 281 800

(Computershare - Company Secretary)

 

[email protected]

 

Strand Hanson Limited

(Nominated Adviser)

Richard Tulloch / James Bellman

 

+44 (0)20 7409 3494

Hybridan LLP

(Broker)

Claire Louise Noyce

 

+44 (0)20 3764 2341

Kinlan Communications

David Hothersall

+44 (0)20 7638 3435

[email protected]

 

About TMT Investments PLC

 

TMT Investments PLC invests in high-growth technology companies across a number of core specialist sectors and has a significant number of Silicon Valley investments in its portfolio.  Founded in 2010, TMT has invested in over 55 companies to date and has net assets of US$102m as of 31 December 2019.  The Company's objective is to generate an attractive rate of return for shareholders, predominantly through capital appreciation.  The Company is traded on the AIM market of the London Stock Exchange.

 

www.tmtinvestments.com .

 

Twitter   LinkedIn

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
HOLBSGDLISDDGGS

a d v e r t i s e m e n t